Strategic regulatory plan

- Invest strategically for a secure route to market

When developing a new medical device, it is crucial to have a well thought-out regulatory strategy. It ensures that the product meets the requirements of each market and saves both time and resources. A clear strategy can reduce the risk of costly mistakes and speed up market access.

What is a regulatory strategy - and why is it needed?

A regulatory strategy is a document that describes the requirements and regulations that apply to products in different markets from conception to aftermarket surveillance. It involves identifying the specific requirements and documentation needs that the product must meet in order to be sold. This is particularly important to meet the Medical Devices Regulation (MDR), In-Vitro Diagnostics Regulation (IVDR) and similar regulations, where documentation of product safety, clinical data and compliance with standards play a central role. By having a well-thought-out strategy, the company can ensure that all steps are taken in the right order and that no unnecessary obstacles arise along the way.

What should be included in a regulatory strategy?

An effective regulatory strategy takes into account several key components, each of which contributes to the product's success in the market:

  • Market requirements and regulations: For each market where the product is to be sold, the strategy needs to define the product requirements, documentation and burden of proof.
  • Documentation and standards: An important part is to create and follow technical files, tests and standards for the product to pass the necessary audits.
  • Clinical data: Many products require clinical studies, which involve carefully planned tests on humans to verify safety and efficacy. The strategy here needs to outline the need for clinical data and plan for time and budget.
  • Registration requirements: Depending on the product category, the product may require review and approval by an independent third party. This often requires additional resources and planning.

 

These components are essential for the product to be launched in a given market. A regulatory strategy provides clear guidance on which requirements are key and minimizes the risk of surprises and wrong decisions.

The balance between time, cost and regulatory risk

In product development, there is always a balance between time, cost and getting the product to meet regulatory requirements. Companies need to make balanced decisions about which markets to launch in, as well as the product's intended use and design, as these decisions affect regulatory requirements and thus both costs and timelines.

Practical tips for creating a sustainable regulatory strategy

A successful regulatory strategy must be both flexible and robust. Here are some practical tips:

  1. Start early: It is wise to start planning the strategy in the early stages of development to identify any regulatory barriers before the design is finalized.
  2. Gather and document relevant information: A thorough mapping of product specifications and market requirements is a cornerstone of an effective strategy. Make sure to define the product use and market to identify the specific requirements.
  3. Update regularly: Regulations and conditions are constantly changing in Medtech. Update the strategy regularly to ensure it remains relevant and aligned with current requirements and technological advances.

 

A blueprint for success in a regulated world

Having a well thought-out regulatory strategy is often crucial to success in the medical device industry. A clear plan for documentation, clinical data and approvals enables the product to be launched in a timely and cost-effective manner, helping to improve the quality of life of users worldwide. With a sustainable regulatory strategy in Location , even the most complex product development is supported and the company can navigate confidently in an ever-changing regulated world.

Subject matter expert

Pascal Skoglund, Consultant at Plantvision AB
Pascal Skoglund
Head of Unit Medtech & IVD

Subject matter expert

Pascal Skoglund, Consultant at Plantvision AB
Pascal Skoglund
Head of Unit Medtech & IVD

In this article

Related content

Medtech & IVD
Are you ready for QMSR on February 2, 2026?
Read more
Life Science
How does the European Health Data Space affect the life sciences industry?
Read more
Medical Device Software
The road to an eQMS
Read more
Medtech & IVD
Are you ready for QMSR on February 2, 2026?
Read more
Life Science
How does the European Health Data Space affect the life sciences industry?
Read more
Medical Device Software
The road to an eQMS
Read more
Stay up to date

SUBSCRIBE to our newsletter